In an exciting medical breakthrough, the U.S. Food and Drug Administration (FDA) has approved two sickle cell treatments, including the first to use gene-editing tool CRISPR. Hundreds of thousands of people around the world — mostly people of colour — live with this painful condition that shortens a person’s lifespan. Farah Nasser explains how the new therapy works, and what else it could be used for.
Health
U.S. FDA approves 2 sickle cell gene therapies in medical breakthrough
More Videos
-
‘No such thing as a perfect parent’: More than half of parents say they’re burned out
-
No concern about a ‘diminished supply’ of doctors in Ontario: ministry
-
Gene variant causes 15-20% of Alzheimer’s cases: Study
-
Health Matters: Researchers create virus detection network
-
Health minister demands Conservatives to stop blocking free contraceptives for women across Canada
-
Health Matters: CFIA steps us avian influenza surveillance
You are viewing an Accelerated Mobile Webpage.
View Original Article